PCIA
VIE

Prime Capital Investment Advisors’s Viela Bio, Inc. Common Stock VIE Stock Holding History

Prime Capital Investment Advisors’s Portfolio VIE Stock Details VIE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-200
Closed -$8K – 545
2020
Q1 		$8K Buy
+200
New +$7.79K ﹤0.01% 416

Other funds holding VIE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Prime Capital Investment Advisors's VIE Position: Q2 2020 in Review

Prime Capital Investment Advisors sold out of Viela Bio, Inc. Common Stock (VIE) in Q2 2020, closing a stake of 200 shares — an estimated $8K sold.

Prime Capital Investment Advisors first reported a position in VIE in Q1 2020 and held it in 1 quarter. The position peaked at $8K in Q1 2020. 65 funds tracked by Wall St. Rank hold VIE as of Q2 2020.

  • Prime Capital Investment Advisors reported no remaining Viela Bio, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
  • Prime Capital Investment Advisors sold 200 Viela Bio, Inc. Common Stock shares in Q2 2020, an estimated $8K.
  • Prime Capital Investment Advisors first reported a position in Viela Bio, Inc. Common Stock in Q1 2020 and held it in 1 quarter.
  • Prime Capital Investment Advisors's Viela Bio, Inc. Common Stock position peaked at $8K in Q1 2020.
  • 65 funds tracked by Wall St. Rank held Viela Bio, Inc. Common Stock as of Q2 2020.

Based on Prime Capital Investment Advisors's 13F filing for Q2 2020, filed 17 Jul 2020.